Bio Spin-off Day How to start my own spin-off ?

Bio Spin-off Day
How to start my own spin-off ?
Date:
Wednesday April 29, 2009 , 13:00 h – 19:00
Place:
Auditorium 200L00.06 (Celestijnenlaan 200, 3001 Leuven)
Program:
13:00 Welcome Coffee and sandwiches
14:00 Opening Remarks
Bart De Moor, co-ordinator BioSCENTer and chairman IOF Board
14:10 VIB’s approach to life science start-ups
Chris De Jonghe, Business Development Manager VIB, www.vib.be
Amongst VIB's most visible tech transfer outcomes are the novel life science enterprises it establishes. In
close collaboration with the researchers, VIB follows an up-to-the-elbow approach to build platforms that
can form the basis of a new company, to develop a business plan, to identify experienced managers to run
the company and to attract national or international investors willing to invest in the start-up. VIB’s
approach will be exemplified with real-life cases.
14:35 Spinning out in Leuven
Paul Van Dun, General Manager LRD, www.kuleuven.be/lrd
Spinoffs don’t come out of the blue. Many years of research are ahead of a start up and when at the end
there finally is a concept on the table the question rises in which context a spin-off is (not) recommended?
In addition, at the final start up all kinds of issues are emerging.
How does this starting process come along in Leuven and what kind of instruments can be used?
Which financial support can be provided to researchers and to whom can they address their questions?
Overview of the birth of a spin-off.
1
15:00 Starting & growing university spin-offs: real life experiences
Rudi Cuyvers, Innovation Manager, Cell Spin-offs and Innovation, www.kuleuven.be/lrd
The basic ingredients & challenges to start-up & grow university spin-offs are clarified by means of five
case studies in the bioinformatics & biotechnology field: Algonomics, Cartagenia, Fugeia, Remynd, Silicos.
Despite the large diversity in technologies & applications, the five spin-offs show that a common set of
key success factors can be identified and have to be taken into account by the different parties
participating in a spin-off project.
15:30 Opportunities for funding of spin-off initiatives by IWT
Maarten Sileghem, Director Strategic and European Research IWT, www.iwt.be
IWT is a Flemish agency that provides financial support to R&D proposals with an economic output. IWT
offers opportunities for spin-off initiatives at different levels. Start-up companies can receive direct
financial support for R&D projects. In this funding scheme, the company always needs to finance a
proportion of the project. For start-ups with restricted financial means, support will be committed on a
conditional basis beyond the financial capacity of the company at the moment of evaluation. In this
situation, the support follows the growth of a young company. Project support can even be committed
prior to the foundation of a company. Start-ups can also receive support for feasibility studies, including
funding for the preparatory phase of writing business plans. Finally, low-interest loans can be provided on
top the subsidy without the need for an additional proposal.
University groups with the aim to work towards a spin-off can receive support for the basic strategic
research that lays the foundations for a later spin-off. Since 2004, this possibility is integrated in the SBO
programme in which 100% subsidy is provided to universities and research institutes. Up to 20% of the
budget (around 5 million euro per annum) can be allocated to projects with a major focus on the creation
of a spin-off. In addition, individual researchers can be supported through a research fellowship with a
specific focus on the creation of a spin-off.
15:55 Coffee Break
16:15 Short Introduction
Jan Beirlant, Dean of the Faculty of Science, on behalf of Jos Peeters, President of
Science@Leuven
2
16:20 The financing of start-ups in challenging times
Patrick Van Beneden, Executive Vice-President Life Sciences GIMV, www.gimv.be

How to get financing in this difficult environment?

Investment criteria

What are VCs looking for? What not?

What has changed/is changing?

How to get an exit for investors/shareholders?

Some cases: Devgen, Ablynx, ActoGeniX,…
16:45 Students and Synthetic Biology: future entrepreneurs?
K.U.Leuven, iGEM 2008 Team (represented by Jonas Demeulemeester, Hanne Tytgat)
www.kuleuven.be/bioscenter/igem)
Imagine a bacterium that produces a drug when and where it is needed in the human body. It would have
several advantages over classical drugs and could have many medical applications. In this framework, the
K.U.Leuven participated in 2008 to the international Genetically Engineered Machines (iGEM) competition
with Dr. Coli, the bacterial drug delivery system. Dr. Coli senses the disease signal and produces the
appropriate amount of drugs to meet the individual patient’s needs. And when the patient is cured, Dr.
Coli self-destructs. To do this, his molecular timer registers the time since the last disease signal sensed.
But when the disease flares up again, this timer is reset and drug production is resumed. Dr. Coli is an
example of synthetic biology, a new discipline that combines biology with engineering principles to design
and construct new biological systems with useful properties. Within the time frame of the iGEM
competition, the team developed a proof of concept of Dr. Coli. The most important assets are massive
reuse of standard BioBricks, different control mechanisms and extensive modeling. The K.U.Leuven 2008
iGEM team won a golden medal for their design of Dr. Coli in the first participation of a Belgian team in
iGEM ever.
17:10 Biopharmaceutical drug development between academia and industry: a case study
Desiré Collen, Founder and Chairman ThromboGenics, www.thrombogenics.com
Both society and funding agencies expect academia to contribute pro-actively to value generating
applications by performing not only discovery research but also translational research towards new
services and products. A case study of such an interaction between the university of Leuven (KU Leuven),
the Flanders Institute for Biotechnology (VIB) and the biopharmaceutical spin-off ThromboGenics NV
(THR) will be presented, focusing on the relative roles of intellectual property, licensing arrangements,
contract research and translational research in selected areas of biopharmaceutical medicine.
3
17:40 Closing Remarks
Bart De Moor, coordinator BioSCENTer and chairman IOF Board
17:45 Drink
Organisation :
-
BioSCENTer, Leuven Bio-Science, Bio-Engineering & Bio-Technology Center
www.kuleuven.be/BioSCENTer
Arenberg Doctoral School
http://set.kuleuven.be/phd/
Leuven Research en Development
www.kuleuven.be/lrd
Leuven Industrieel Onderzoeksfonds
www.kuleuven.be/iof
Science@Leuven
http://wet.kuleuven.be/alumni/
Leuven Innovation Networking Circle
www.leuveninc.com
4
Curriculum vitae Désiré Collen
Désiré Collen holds a M.D. degree (1968) and Ph.D. degree in Chemistry (1974)
from the University of Leuven, Belgium, and was formerly Director of the Center
for Molecular and Vascular Biology of K.U. Leuven, and of the Vesalius Research
Center of VIB. His team with Genentech Inc developed t-PA for thrombolytic
therapy of AMI. He has co-authored over 650 research papers and has received
the Francqui Prize (Belgium) in 1984, the Prix Louis Jeantet de Médecine
(Switzerland) in 1986, the Bristol-Myers-Squibb award for Cardiovascular Research
(USA) (jointly with M. Verstraete) in 1995, and the Health Prize of the InterbrewBaillet Latour Fund (Belgium) (jointly with P. Carmeliet) in 2005. Dr. Collen is
presently Chairman of ThromboGenics, NV, a biopharmaceutical drug
development company listed on Euronext Brussels.
foto: © <http://www.bartvanleuven.com>.
Curriculum vitae Rudi Cuyvers
Rudi Cuyvers holds a Ph.D. in Electronics (K.U.Leuven) and an MBA degree
(Flanders Business School).
As innovation manager at K.U.Leuven R & D he is head of the Spin-offs &
Innovation unit, which supports spin-off creation & growth and stimulates the
university-industry interaction. He has been involved in the start-up of more than
30 spin-offs, is member of the board of directors in several companies and is an
active partner in several network organizations & projects that promote
innovation and high-tech entrepreneurship
Curriculum vitae Chris De Jonghe
Education:
1990-1994: Licentiate in Biochemistry from University of Antwerp
1994-1999: PhD in Neurogenetics (functional analysis of gene defects causing
Alzheimer’s disease, promoter: Christine Van Broeckhoven)
2004- 2007: Bachelor in laws
Professional Career:
1999-2001: post-doctoral fellow FWO (labs of Christine Van Broeckhoven – UA and
Bart De Strooper – KUL)
2001-2007: licensing manager at VIB
2007-present: business development manager at VIB
5
Curriculum vitae Bart De Moor
Bart De Moor studeerde in 1983 af als burgerlijk elektro-werktuigkundig ingenieur
aan de Katholieke Universiteit Leuven, specialisatie regeltechniek. Hij behaalde er
het doctoraat in de Toegepaste Wetenschappen in 1988. Daarna was hij
gedurende 2 jaar, van 1988 tot 1990, ‘Research Associate’ aan de Stanford
University in Californië, in het ‘Information Systems Lab’ (Prof. Kailath) en het
departement Computerwetenschappen (Prof. Golub). Vandaag is hij Gewoon
Hoogleraar aan het departement ESAT van de K.U.Leuven.
Bart De Moor stond mede aan de wieg van 6 ‘spin-off’ bedrijven van de
K.U.Leuven (IPCOS, Data4s (acquired by Norkom Technologies) TMLeuven, Silicos,
Dsquare, Cartagenia).
Van 1991-1992 was Bart De Moor de kabinetschef van de federale minister van
Wetenschapsbeleid (Wivina Demeester) en van 1994-1999 was hij de adviseur
Wetenschapsbeleid van de minister-president van Vlaanderen (Luc Van den
Brande). In die functie lag hij mee aan de basis van het Vlaams Interuniversitair
Instituut voor Biotechnologie (VIB), het Vlaams Instituut van de Zee (VLIZ), het
Vlaams Centrum voor Bewaring van Tuinbouwproducten (VCBT) en Technopolis. In
2005-2007 was hij als kabinetschef socio-economisch beleid van de Vlaamse
minister-president (Yves Leterme) de coördinator van ‘Vlaanderen-in-actie’.
Hij was lid van de Academische Raad en de Raad Onderzoeksbeleid van de
K.U.Leuven en de raad van bestuur van het StudieCentrum voor Kernenergie (SCK).
Hij is voorzitter van de Raad van Bestuur van Hercules (het Vlaams agentschap
voor de financiering van zware onderzoeksapparatuur), voorzitter van het
Industrieel OnderzoeksFonds (IOF) van de K.U.Leuven, lid van de Raad van Bestuur
van het Vlaams Instituut voor Biotechnologie (VIB), het Interdisciplinair instituut
voor BreedBandTechnologie (IBBT), het Vlaams Centrum voor Bewaring van
Tuinbouwproducten (VCBT) en verschillende binnen- en buitenlandse
wetenschappelijke en culturele verenigingen.
Curriculum vitae Maarten Sileghem
Maarten Sileghem was trained as a biotechnologist and obtained the degree of
PhD in Sciences with specialisation in cellular immunology at the Free University
Brussels in1988. His research was on suppression of the immune system with a
focus on cytokines and macrophages using a tropical disease as a model system. In
1989 he became a postdoctoral research fellow at ILRAD, an international research
institute within the CGIAR, a consortium affiliated with the World Bank and the
UN. As an employee of the UN, he became project leader in de same institute in
6
1992 shifting towards management of a research team on strategic biotech
research with a long-term economic output. For seven years he was based in
Nairobi, Kenya, as an expatriate.
In 1996 he joined IWT, an agency with a mandate to stimulate innovation in
Flanders, Belgium. As a scientific advisor he became responsible for evaluation of
R&D proposals in the field of biotechnology. He was mainly involved in industrial
R&D and strategic research, with a major focus on biotech start up companies and
on R&D projects with valorisation on a global scale. In 2002 he became team
leader, coaching a team of several advisors active in de field of Life Sciences. In
2007 he became Director Strategic Research and European Programmes at IWT.
He has an overall responsibility for strategic research programmes and
international collaborations.
Curriculum vitae Paul Van Dun
As of december 2000 Paul is active within K.U.Leuven Research & Development,
the technology transfer unit of K.U.Leuven, where he is general manager and
coordinates the activities in contract research, patenting, licensing, spinoff
creation and regional development. He is also managing director of the venture
funds Gemma Frisius Fund I & II, board member of the Fondation Fournier-Majoie
pour l’Innovation and Capricorn Venture Fund II, and board member or president
of several spinoff companies. As of 2006, he has been elected vice-president of
ASTP (Association of European Science & Technology Transfer Professionals).
Curriculum vitae Patrick Van Beneden
Patrick Van Beneden (1962) has worked at Gimv since 1985 and joined the
Executive Committee in February 2001. He heads up the Life Sciences business unit.
He is a board member of various listed and non-listed investments, including
Acertys, ActoGeniX, Astex, DeVGen, Pamgene, TorreyPines Therapeutics and the
Biotech Fonds Vlaanderen. Former board seats include Innogenetics, Crucell,
Avalon, Hypnion (acquired by Eli Lilly) and Crop Design (acquired by BASF).
Patrick Van Beneden has a degree in Financial Sciences from VLEKHO in Brussels.
7
8
K.U.Leuven Bio Spin-off Day – 29/04/2009
List of Participants
Wouter Achten
K.U.Leuven
Dept. Earth & Environmental Sciences
Tom Beyers
K.U.Leuven
M³S/CMPG
Simona Capponi
K.U.Leuven
ATF/Physics
Adefioye Adeshola
K.U.Leuven
ESAT/SCD (SISTA)
Bart Boeckmans
Groep T - Leuven Engineering College
Valérie Cappuyns
HUBrussel
CEDON
Luc Alaerts
K.U.Leuven
Microbial and Molecular Systems
Sven Arnouts
UGent
PROVAXS
Animesh Kumar Basak
K.U.Leuven
MTM
Kristien Bonroy
Tibotec
PMO
Stijn Bossin
Groep T - Leuven Engineering College
Erikbrie Briers
Alumnus Chemistry Dep.
Nanomaterials (macromolecular
chemistry)
Geert Behets
University of Antwerp
Laboratory of Pathophysiology
Paula Bruggen
K.U.Leuven
Computerwetenschappen- Numerieke
Analyse
Jan Beirlant
Fac. Wetenschappen
Dries Bruyneel
Groep T - Leuven Engineering College
Iryna Benilova
VIB
Dept. Molecular & Devel. Genetics
Yvan Bruynseraede
K.U.Leuven
Physics and Astronomy
Dries Berckmans
K.U.Leuven
Mechanical Engineering
Bruno Cammue
K.U.Leuven
M2S / CMPG
Nele Berthels
K.U.Leuven
R&D
Angels Cano Odena
K.U.Leuven
M2S, Center for Surface Chemistry
and Catalysis (COK)
Astrid Cappuyns
K.U.Leuven
CIT - BioTeC
Eric Castille
Tiense Suikerraffinaderij NV
Director Market Development
Nikos Chatziathanasiou
K.U.Leuven
MTM
Yunan Cheng
IMEC
NEXTNS
Andrew Chibeu
K.U.Leuven
Division of Gene Technology
Yi-Jen Chuang
Université Catholique de Louvain
Unit of Pharmacology and
Therapeutics (FATH)
Soetkin Claes
K.U.Leuven
Bio-engineer cell & gentechnology
Vanja Cnops
K.U.Leuven
Biomedische wetenschappen
9
Désiré Collen
Thrombogenics
K.U.Leuven
Sigrid De Keersmaecker
K.U.Leuven
M2S/CMPG
Eileen Dejaegere
VUB
Chemical Engineering
Koen Cornelissens
K.U.Leuven
ESAT/MICAS
Wim De Malsche
VUB
Chemical Engineering
Joachim Deldime
Groep T - Leuven Engineering College
Jeroen Corthout
Vlerick Leuven Gent Management
School
Masters in General Management
Bart De Moor
K.U.Leuven
BioSCENTer
Jan Costermans
Groep T - Leuven Engineering College
Alexander Crawford
K.U.Leuven
Dept. Pharmaceutical Sciences
Thomas Crispeels
Vrije Universiteit Brussel
Department of Business Economics
and Strategic Management
Armando De Palma
Rega Institute for Medical Research
Microbiology and Immunology
Dorien De Pooter
Groep T - Leuven Engineering College
Raoul De Schutter
Groep T - Leuven Engineering College
Nicole De Smyter
Leuven.Inc
Peter Delputte
UGent
PROVAXS
Mekonnen Demeke
K.U.Leuven
Biology
Jonas Demeulemeester
K.U.Leuven
Guy Derdelinckx
K.U.Leuven
M²S
Jan Develter
Laboratory for Pharmaceutical Biology
Faculty of Pharmaceutical Sciences
Harry Cuppens
KULeuven, Faculty of Medicine
Center for Human Genetics
Jeremy De Sy
Vrije Universiteit Brussel
R&D - Technology Transfer Interface
Rudi Cuyvers
K.U.Leuven
LRD
Hannes De Wachter
K.U.Leuven
LRD
Patrick D'Haese
University of Antwerp
Laboratory of Pathophysiology
Melina Daans
K.U.Leuven
Stijn Debaene
Allen & Overy LLP
Wilfried D'Haese
PricewaterhouseCoopers
Hans Danneels
K.U.Leuven
ESAT/MICAS
Wouter Deburchgraeve
K.U.Leuven
ESAT/SCD (SISTA)
Daisy Di Pardo
Groep T - Leuven Engineering College
Tina De Greef
K.U.Leuven
LRD
Sophie Deckx
Groep T - Leuven Engineering College
Cristina de Joncheere
IMEC
Business development
Priscilla declerck
Lab of Aquatic Ecology and
Evolutionary Biology
Biology
Chris De Jonghe
VIB
David Decoster
Groep T - Leuven Engineering College
Frederic Devisch
Barco Silex
Nicolas Dierckxsens
Groep T - Leuven Engineering College
Matteo Donadoni
Vlerick Leuven Gent Management
School
Masters in General Management
Emmie Dornez
K.U.Leuven
Department of Microbial and
Molecular Systems
10
Ignace Dufaux
Groep T - Leuven Engineering College
Filip Frederix
NXP
ULPS
Hans Goesaert
K.U.Leuven
R&D
Wim Fyen
K.U.Leuven
R&D
Marc Goldchstein
vrije universiteit brussel
BEDR
Wolfgang Eberle
IMEC
Bioelectronic Systems
Jellert Gaublomme
IMEC
FNS
Tiny Grauwels
Groep T - Leuven Engineering College
Svetlana Ebzeeva
K.U.Leuven
MTM
Kurt Gebruers
Laboratory of Food Chemistry and
Biochemistry
M2S
Eric Dy
IMEC/KU Leuven
Heterogeneous Integrated
Microsystems
Jan Eggermont
K.U.Leuven
Doctoral School Biomedical Sciences
Hamed Eghbali
VUB
CHIS
Sri Ramulu Elluru
K.U.Leuven
Yves Engelborghs
K.U.Leuven
Biochemistry
Kristof Engelen
K.U.Leuven
M2S
Denis Ermolat'ev
K.U.Leuven
Faculty of Science, Chemistry
Department
Maarten Fauvart
K.U.Leuven
M2S/CMPG
Joachim Ferreau
K.U.Leuven
ESAT/SCD (SISTA)
Ellen Fierens
K.U.Leuven
Lab, Levensmiddelenchemie en biochemie
Minne Geeraert
Atherosclerosis and Metabolism
Cardiovascular diseases
Reinout Grommen
Groep T - Leuven Engineering College
Willyan Hasenkamp Carreira
K.U.Leuven
Faculty of Engineering
Niels Haverbeke
K.U.Leuven
ESAT/SCD (SISTA)
Stefan Germeau
Koen Hendrickx
Nick Geukens
PharmAbs
K.U.Leuven Antibody Center
Tine Holemans
Groep T - Leuven Engineering College
Peter Geunes
Groep T - Leuven Engineering College
Nathalie Hooylaerts
Groep T - Leuven Engineering College
Olivier Gevaert
K.U.Leuven
ESAT/SCD (SISTA)
Bruno Hoste
K.U.Leuven
Industrieel onderzoeksfonds - DOC
Subir Kumar Ghosh
K.U.Leuven
Dept MTM
Marnix Housen
Incubatiecentrum ICAB
Thomas Gielis
Groep T - Leuven Engineering College
Chengjun Huang
IMEC
NEXT
Lieve Gilis
K.U.Leuven
Faculteit Wetenschappen
Ernesto Iacucci
K.U.Leuven
ESAT/SCD (SISTA)
Ivan Gligorijevic
K.U.Leuven
SISTA/SCD
Elsy Ibrahim
K.U.Leuven
Civil ENgineering
Bruno Goddeeris
K.U.Leuven
Biosystems
Abdelilah Ibrahimi
K.U.Leuven
Lab. Molecular Virology & Gene
Therapy Div. Molecular Medicine
11
Ingrid Ilsbroux
Groep T - Leuven Engineering College
Koen Langie
Groep T - Leuven Engineering College
Kristof Jacobs
Groep T - Leuven Engineering College
Sarah Lebeer
K.U.Leuven
Centre of Microbial and Plant
Genetics
Siegfried Jaecques
K.U.Leuven
Leuven Medical Technology Centre (LMTC)
Murali Jayapala
IMEC vzw
SSET
Vinay Jayaram
K.U.Leuven
Dept. of Microbial and Molecular
Systems (M2S)
Pieter-Jan Jordaens
Groep T - Leuven Engineering College
Becker Julien
Université de Liège
Bioinformatique
Harish Nag Kankipati
K.U.Leuven
Dept of Molecular Microbiology
Jelle Machiels
Groep T - Leuven Engineering College
Thomas Lelièvre-Damit
Groep T - Leuven Engineering College
Gregory Maes
Laboratoy for Animal Diversity and
Systematics Biology
Daniele Leonelli
K.U.Leuven
ESAT
Inge Lerouge
K.U.Leuven
Dienst Onderzoekscoördinatie
Steven Leuridan
K.U.Leuven
BMGO
Yue Li
K.U.Leuven
Department of Biosystems (BIOSYST)
Bert Kegels
BDO Atrio
Bruno Kersschot
K.U.Leuven
Werktuigkunde/PMA
Sophie Lintermans
K.U.Leuven
bio-engineering
Peter Kupers
K.U.Leuven
Department of Arts - Japanology
Chengxun Liu
IMEC
BIONE
Karl Gaston Lafaut
Dirk Loeckx
K.U.Leuven
Medical Image Computing (ESAT/PSI)
Wilfried Langenaeker
Silicos
Walter Luyten
K.U.Leuven
Vrouw en Kind
Jonas Lejeune
Groep T - Leuven Engineering College
Zhen Li
IMEC
FNS
Bart Landuyt
K.U.Leuven
Biology/Functional Genomics and
Proteomics
Ivan Lule
K.U.Leuven
Chemical Engineering
Hugo Loosvelt
Vrije Universiteit Brussel
Technology Transfer Interface
Shujue Lou
Groep T - Leuven Engineering College
Wouter Maes
K.U.Leuven
Earth and Environmental Sciences
Koen Maes
Groep T - Leuven Engineering College
Karel Maesenaere
VOKA - Kamer van Koophandel Flanders Smart Hub
Belangenbehartiging/Research
Hagen Marien
K.U.Leuven
MICAS
Tine Meekers
K.U.Leuven
Biology, Plant Ecology
Ingrid Merchiers
Coordinator IOF
UGent Techtransfer
Kristof Mertens
K.U.Leuven
Biosystems/MeBioS
Pascal Mertens
K.U.Leuven
Centre for Surface Science and
Catalysis, Dept. Microbial & Molecular
Systems
Sarah Meys
K.U.Leuven
geo - ees
12
Servaas Michielssens
K.U.Leuven
chemistry
Luc Mortelmans
UZ Gasthuisberg
Nuclear Medicine
Stoffel Mulier
SO Kwadraat
Silke Musa
IMEC
BIONE/BES
Peter Nelissen
Groep T - Leuven Engineering College
Hoang Anh Nguyen Ngoc
K.U.Leuven
Dept. Microbial and Molecular
Systems (M2S)
Fabian Ojeda
K.U.Leuven
Electrical Engineering
Liesbet Paemen
De Clercq, Brants & Parnters
Lesley Pandey
K.U.Leuven
Chemistry
Bram Pareyt
Laboratory of Food Chemistry and
Biochemistry
M2S
Liesbet Peeters
gene technology
biosystems
Ruben Peeters
Advocatenkantoor Peeters
Sofie Peeters
Groep T - Leuven Engineering College
Jan Peirs
K.U.Leuven
Mechanical Engineering
Juan Carlos Perez Guerra
Koen Pieters
Groep T - Leuven Engineering College
Bjorn Possé
UGent
Technology Transfer
Jun Qian
K.U.Leuven
PMA
Abdul Rauf
K.U.Leuven
MTM, Chemical
Serge Remy
K.U.Leuven
Dep. of Biosytems/Div. of Crop
Biotechnics
Bert Reubens
K.U.Leuven
Earth and Environmental Sciences
Toon Reynders
Groep T - Leuven Engineering College
Johan Robbens
Universiteit Antwerpen
Ben Rockefeller
Ivo Roelants
K.U.Leuven
LRD
Frederik Saman
Groep T - Leuven Engineering College
Aminael Sanchez
K.U.Leuven
Microbial and Molecular systems /
CMPG
Kristien (Tine) Schaerlaekens
K.U.Leuven
Labo Moleculaire Celbiologie
Leander Schietgat
K.U.Leuven
Department of Computer Science
Jan Schrooten
K.U.Leuven
MTM / Prometheus
Bert Schuyten
Groep T - Leuven Engineering College
Mauro Sette
K.U.Leuven
BMGO, Mechanical Dept.
Tina Shahani
K.U.Leuven
Cardiovascular and Molecular biology
Aydar Shakirov
Venture Fund
Law
Ilse Sienaert
Innovatiecentrum Vlaams-Brabant
Hassan Rokni Zadeh
K.U.Leuven
CMPG
Maarten Sileghem
IWT
Philippe Rooseleer
Fibiz Partners
Mitchell Silva
K.U.Leuven
M3BIORES
Sofie Saerens
K.U.Leuven
Microbial and Molecular Systems
Pieter Slagmolen
K.U.Leuven
Medical Imaging Research Center
Daan Saison
K.U.Leuven
Dept. Microbiële en Moleculaire
Systemen
Nathalie Sonck
K.U.Leuven
CeSO
13
Olivier Sondervorst
Bird & Bird
zhigang song
K.U.Lfeuven
Department of Biosystems (BIOSYST)
Stijn Spaepen
K.U.Leuven
M2S
Jan Struyf
K.U.Leuven
Computer Science
Sanne Tambeur
Groep T - Leuven Engineering College
Hsiao Wei Tang
K.U.Leuven
PMA
Thomas Teirlinck
Groep T - Leuven Engineering College
Adrien Tham-vo
HEC-Paris
Entrepreneurship
Karin Thevissen
CMPG-PFI
M2S
Bert Thewissen
Laboratory of Food Chemistry &
Biochemistry
Microbial and Molecular Systems
(M2S)/Centre for Food and Microbial
Technology
Stéphanie Theyskens
Groep T - Leuven Engineering College
Inge Thijs
K.U.Leuven
Dept. Microbial and Molecular
Systems
Deepak Balaji Thimiri govinda raj
K.U.Leuven
Centre for human genetics
Gitte Tielens
Jaan Toelen
K.U.Leuven
Molecular Medicine, Molecular
Virology
Antonia Torcasio
K.U.Leuven
Mechanical Engineering / BMGO
Hanne Tytgat
K.U.Leuven
Jan Valckx
K.U.Leuven
Afdeling Bos, Natuur en Landschap
Brawley Valkenborgs
Groep T - Leuven Engineering College
Koen Van Aken
EcoSynth
Green Chemistry
Patrick Van Beneden
GIMV
Wouter Van Delm
K.U.Leuven
ESAT
Tom Van Herpe
K.U.Leuven
ESAT/SCD (SISTA)
Wilfried van Herterijck
K.U.Leuven
ESAT
Roel Van Hollebeke
Van Hollebeke & Co
Hans Van Hooland
VUB
IMDO
Jeroen Van Houdt
K.U.Leuven
Biology
Johan Van Lint
K.U.Leuven
Fac. Geneeskunde, Moleculaire
Celbiologie
Sebastiaan Van Mulders
K.U.Leuven
Department of Microbial and
Molecular Systems
Wim Van den Boeck
Arnold & Siedsma
Wim Van Snick
K.U.Leuven
Chemistry
Kirsten Van den Bogaert
Groep T - Leuven Engineering College
Diederik Van Tricht
Groep T - Leuven Engineering College
Barend Van den Brande
Big Bang Ventures
Nele Vanbeneden
K.U.Leuven
M²S
Dimitry Van der Zande
K.U.Leuven
M3-BIORES
Paul Van Dun
K.U.Leuven
LRD
Ward Van Duppen
Groep T - Leuven Engineering College
Maarten Van Guyse
K.U.Leuven
CMPG, fac. bio-engineering
Steven Vandeput
K.U.Leuven
ESAT/SCD (SISTA)
Jef Vanderoost
K.U.Leuven
Biomechanics and Engineering Design
Jeroen Vandersteen
K.U.Leuven
Sterrenkunde
14
Joos Vandewalle
K.U.Leuven
ESAT/SCD (SISTA)
Jan Vandommele
BDO Atrio
Kevin Vangrunderbeeck
Groep T - Leuven Engineering College
Els Vanheusden
Capricorn Venture Partners
CHF
Ruth Venmans
Groep T - Leuven Engineering College
Pieter Verboven
K.U.Leuven
BIOSYST-MeBioS
Bert Verbruggen
K.U.Leuven
MeBioS - Biosensor group
Johan Verbruggen
b.v.b.a. J. Verbruggen
Ann Vereecken
Groep T - Leuven Engineering College
Kirsten Welkenhuyzen
Groep T - Leuven Engineering College
Bert Verlinden
Flanders Centre of Postharvest
Technology
Biosyst/Mebios
Lianggong Wen
K.U.Leuven
MICAS
Steven Vermeir
K.U.Leuven
BIOSYST/MeBioS
Edith Wilderjans
Laboratory of food chemistry and
biochemistry
microbiële en moleculaire systemen
Herman Verrelst
Medicim
Kenneth Wils
ParticipatieMaatschappij Vlaanderen
Willem Verstraeten
K.U.Leuven
Geomatics - Biosytems
Ronald Wintzéus
Imcron
Kris Verstreken
IMEC
Gunther Wuytens
K.U.Leuven
Research and Development
Maxime Vincent
Groep T - Leuven Engineering College
Chunhui Ye
Groep T - Leuven Engineering College
Lore Vinken
Groep T - Leuven Engineering College
Edwin Zimmerman
PMV
David Zwaenepoel
ReGenesys
Bio-engineer
15
16